| |
|
|
|
Xtalks, Online
2024-10-03
Join this informative webinar that analyses the challenges of globalization in pharmacovigilance (PV), how to overcome them, remain within regulatory compliance and build inspection-readiness best practices.
Pharmaceutical companies have expanded their operations to a global scale. Patients now have exceptionally easy access to medicines and vaccines and to different treatment options. However, this globalization, whilst beneficial, has introduced significant PV challenges for the marketing authorization holders.
Companies must now navigate a labyrinth of diverse local and regional PV requirements, contend with language barriers and manage an ever-increasing volume of safety data. Rapid and accurate evaluation of this data is essential to protect the patients and safeguard public health. Overcoming these challenges requires a comprehensive understanding of global PV regulations, sophisticated tools and expertise across multiple disciplines.
Read more...
Register for this webinar today to gain insights into navigating the diverse regulatory landscapes and managing the intricate challenges of pharmacovigilance.
Keywords: Pharmaceutical, Pharmaceutical Industry, Drug Development, Pharmaceutical Manufacturing, Clinical Research, CRO, Pharmacovigilance, Regulatory, PV, Toxicology/Safety
|
|
|
|
|
|
|
|
Organized by:
|
|
Xtalks |
|
|
Invited Speakers:
|
|
Ian Kovacs, PhD, Global Head of Pharmacovigilance, Allucent
Georgia Kolangi, MSc, Associate Director, Pharmacovigilance, Allucent
Dr. Ernesto Vera-Sanchez, MD, PhD, MPH, Vice President, Department Head GxP Strategy, Allucent
|
|
|
|
|
|
|
|
Deadline for Abstracts:
|
|
2024-10-03
|
|
|
|
|
|
|
|
Registration:
|
|
Free Registration
|
|
|
E-mail:
|
|
tristan@xtalks.com
|
|
|
|
|
|
|
|
|